Drawing for TUMME

USPTO serial 79355169

TUMME

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
BLAZICH, JOAN MICHELE
Law office
TMO LAW OFFICE 122

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TUMME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Dietetic food supplements; food supplements for medical purposes; medicated food supplements; mineral food supplements; nutritional supplements; nutritional supplements for medical use; probiotic bacterial formulations for medical use, namely, probiotic dietary food supplements for the management of irritable bowel syndrome (IBS) symptoms; collagen-based medicated food supplements; vitamin supplements; vitamin tablets; vitamins; dietetic preparations adapted for medical use; homeopathic medicines for the management of irritable bowel syndrome (IBS) symptoms; homeopathic pharmaceuticals for the management of irritable bowel syndrome (IBS) symptoms; homeopathic supplements; pharmaceutical compositions, namely, pharmaceutical preparations for the management of irritable bowel syndrome (IBS) symptoms; pharmaceutical preparations for the management of irritable bowel syndrome (IBS) symptoms; pharmaceutical preparations for the management of irritable bowel syndrome (IBS) symptoms for health care; medicines for the management of irritable bowel syndrome (IBS) symptoms for human use; medicinal preparations for the management of irritable bowel syndrome (IBS) symptoms; medicinal food supplements; pastilles for pharmaceutical purposes, namely, medicated confectionery; pharmaceutical sweets, namely, medicated confectionery; herbal dietary supplements; dietary food supplements; protein dietary supplements; yeast dietary supplements; antioxidant food supplements; enzyme dietary supplements; plant extracts for pharmaceutical use, namely, herbal food supplements; dietary supplements; pharmaceutical preparations for the management of irritable bowel syndrome (IBS) symptoms; pharmaceutical products for the management of irritable bowel syndrome (IBS) symptomsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 19, 2025FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 3, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 3, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 3, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 3, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 7, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 17, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 20, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Feb 20, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 20, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 1, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2023RFNTREFUSAL PROCESSED BY IB
Aug 18, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 18, 2023RFRRREFUSAL PROCESSED BY MPU
Jul 22, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 21, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2023DOCKASSIGNED TO EXAMINER
Jun 4, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 26, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Nov 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance